Abstract Context Prostate cancer (PCa) is a complex disease that disproportionately impacts
Black men in the USA. The structural factors that drive heterogeneous outcomes for patients …

Immunotherapy remains to be an appealing treatment option for prostate cancer with some
documented promise. Prostate cancer is traditionally considered as an immunologically …

Importance Prostate cancer (PCa) disproportionately affects African American men, but
research evaluating the extent of racial and ethnic disparities across the PCa continuum in …

Importance Prostate cancer (PCa) is marked by disparities in clinical outcomes by race,
ethnicity, and age. Equitable enrollment in clinical trials is fundamental to promoting health …

Cancer death rates vary among population groups. Underserved populations continue to
experience an excessive burden of lethal cancers that is largely explained by health-care …

Prostate cancer exerts a greater toll on African American men than on White men of
European descent (hereafter referred to as European American men): the disparity in …

Avoidable differences in the care and outcomes of patients with cancer (ie, cancer care
disparities) emerge or worsen with discoveries of new, more effective approaches to cancer …

Black men with prostate cancer have historically had worse outcomes than white men with
prostate cancer. The causes of this disparity in outcomes are multi-factorial, but a potential …

The distinct impacts of race and genetic ancestry on health | Nature Medicine Skip to main
content Thank you for visiting nature.com. You are using a browser version with limited support …

African-American (AA) men are more likely to be diagnosed with and die from prostate
cancer than European American (EA) men. Despite the central role of the androgen receptor …